Skip to content
PoliticalRepoPoliticalRepo

Subjects · United States

Healthcare

Records whose title is actually about this topic. Use a country filter if the list is still too broad.

1,467 records in US in 2019

Records

Bill· HRH.R. 127 (116th)referred

CARERS Act of 2019

United States · United States Congress · 3 January 2019

Compassionate Access, Research Expansion, and Respect States Act of 2019 or the CARERS Act of 2019 This bill removes restrictions on, and creates new protections for, conduct and activities related to medical marijuana that are authorized by state law. Among other things, the bill does the following: eliminates regulatory controls and administrative, civil, and criminal penalties under the Controlled Substances Act for producing, possessing, distributing, dispensing, administering, testing, recommending, or delivering medical marijuana in compliance with state law; establishes a new, separate registration process to facilitate medical marijuana research; and authorizes health care providers employed by the Department of Veterans Affairs to make recommendations to veterans regarding participation in state marijuana programs.

Bill· HRH.R. 90 (116th)referred

Protection from Obamacare Mandates and Congressional Equity Act

United States · United States Congress · 3 January 2019

Protection from Obamacare Mandates and Congressional Equity Act This bill alters provisions relating to the requirement to maintain minimum essential health care coverage (i.e., the individual mandate), as well as provisions relating to health care coverage for certain executive branch and congressional employees. Specifically, the bill exempts individuals from the requirement to maintain minimum essential health care coverage if they reside in a county where fewer than two health insurers offer insurance on the health insurance exchange. (Under current law, effective January 1, 2019, there is no penalty for failing to maintain minimum essential health care coverage.) The bill also requires certain executive branch and congressional employees to participate in health insurance exchanges. Under current law, Members of Congress and their designated staff are required to obtain coverage through health insurance exchanges, rather than the Federal Employee Health Benefits (FEHB) Program. Current regulations authorize government contributions toward such coverage and require Members of Congress to designate which members of their staff are required to obtain coverage through an exchange. The bill requires all congressional staff, including employees of congressional committees and leadership offices, to obtain coverage through an exchange. The bill also prohibits Members of Congress from having the discretion to determine which of their employees are eligible to enroll through an exchange. Further, the President, Vice President, and executive branch political appointees must also obtain coverage through exchanges, rather than FEHB. The government is prohibited from contributing to or subsidizing the health insurance coverage of the officials and employees subject to this requirement, including Members of Congress and their staff.

Bill· HRH.R. 53 (116th)referred

Infant Protection and Baby Switching Prevention Act of 2019

United States · United States Congress · 3 January 2019

Infant Protection and Baby Switching Prevention Act of 2019 This bill establishes additional requirements that certain hospitals must meet in order to participate in Medicare. Specifically, as a condition of Medicare participation, hospitals and critical access hospitals that provide neonatal or infant care must have appropriate security procedures to reduce the likelihood of infant patient abduction and baby switching. Noncompliant hospitals are subject to specified civil penalties. The bill also establishes criminal penalties for knowingly altering or destroying a newborn's hospital patient records for the purpose of causing the newborn to be misidentified.

Bill· HRH.R. 171 (116th)referred

LUMMA

United States · United States Congress · 3 January 2019

Legitimate Use of Medicinal Marihuana Act or LUMMA This bill transfers marijuana from schedule I to schedule II of the Controlled Substances Act. It also specifies that no provision of the Controlled Substances Act prohibits or restricts activities related to medical marijuana that comply with a state's medical marijuana law. The bill does not affect any federal, state, or local law that regulates or prohibits smoking in public. Under current law, schedule I controlled substances are those that, among other factors, have no currently accepted medical use in treatment in the United States; such substances thus may not be prescribed, administered, or dispensed for medical use. Substances listed in schedules II through V have some accepted medical use and thus may be prescribed, administered, or dispensed for medical use.

Bill· HRH.R. 148 (116th)referred

Byron Nash Renal Medullary Carcinoma Awareness Act of 2019

United States · United States Congress · 3 January 2019

Byron Nash Renal Medullary Carcinoma Awareness Act of 2019 This bill allows states to receive federal payment under Medicaid for 50% of their costs for providing education on the risk of renal medullary carcinoma to individuals with sickle cell disease. (Renal medullary carcinoma is a rare kidney disease usually found in individuals with the sickle cell trait.)

Bill· HRH.R. 117 (116th)referred

NEWBORN Act

United States · United States Congress · 3 January 2019

Nationally Enhancing the Wellbeing of Babies through Outreach and Research Now Act or the NEWBORN Act This bill requires the Health Resources and Services Administration to support pilot programs that address infant mortality. Specifically, grants must be awarded to local and tribal health departments in areas with the highest rates of infant mortality to establish pilot programs that address specified issues, including birth defects, premature births, and sudden infant death syndrome.

Bill· HRH.R. 107 (116th)referred

To amend title XIX of the Social Security Act to sunset the limit on the maximum rebate amount for single source drugs and innovator multiple source drugs.

United States · United States Congress · 3 January 2019

This bill terminates certain limitations regarding drug rebates under Medicaid. Currently, the maximum rebate that drug manufacturers must pay under Medicaid for single-source and innovator multiple-source drugs is 100% of the average manufacturer price of the drug. The bill specifies that this limitation only applies to rebate periods that begin before January 1, 2020.

Bill· HRH.R. 106 (116th)referred

Health and Human Services Hiree Clarification Act

United States · United States Congress · 3 January 2019

Health and Human Services Hiree Clarification Act This bill alters provisions relating to personnel of the Public Health Service. Specifically, the bill states that provisions authorizing the appointment of special consultants or authorizing individual scientists to receive fellowships for the Public Health Service do not authorize the designation, appointment, or employment of any special consultant, fellow, or other employee by an agency outside of the Department of Health and Human Services.

Bill· HRH.R. 71 (116th)referred

To amend the Public Health Service Act to provide for cooperative governing of individual health insurance coverage.

United States · United States Congress · 3 January 2019

This bill establishes which state law governs health insurers offering coverage in multiple states. Specifically, the bill provides that the laws of a state designated by a health insurer (primary state) apply to individual health insurance coverage offered by that insurer in any state (secondary state) if the coverage, states, and insurer comply with the conditions of this bill. Insurers are exempted from any secondary state's laws that would prohibit or regulate the operation of the insurer in that state. The primary state is given sole jurisdiction to enforce its covered laws in any secondary state. The Government Accountability Office must study the effect of this bill on specified health insurance issues.

Bill· HRH.R. 70 (116th)referred

Freedom for Farmers Act of 2019

United States · United States Congress · 3 January 2019

Freedom for Farmers Act of 2019 This bill abolishes the Agency for Toxic Substances and Disease Registry, which is part of the Department of Health and Human Services (HHS); HHS must transfer authority regarding certain national disease and toxic exposure registries to another appropriate HHS entity.

Bill· HRH.R. 64 (116th)referred

Patients First Act of 2019

United States · United States Congress · 3 January 2019

Patients First Act of 2019 This bill requires the National Institutes of Health (NIH) to support stem cell research. Specifically, the NIH must conduct and support basic and applied research to develop techniques for the isolation, derivation, production, testing, and human clinical use of stem cells that may result in improved understanding of, or treatments for, diseases and other adverse health conditions. However, such techniques must not involve (1) the creation of a human embryo for research purposes; (2) the destruction or discarding of, or risk of injury to, a human embryo; or (3) the use of any stem cell the derivation or provision of which would be inconsistent with this bill. The NIH must also report on peer-reviewed stem cell research proposals that were not funded.

Bill· HRH.R. 59 (116th)referred

Transparency and Accountability of Failed Exchanges Act

United States · United States Congress · 3 January 2019

Transparency and Accountability of Failed Exchanges Act This bill establishes specific audit requirements, and rescinds funds, for certain states that are awarded grants to establish health insurance exchanges under the Patient Protection and Affordable Care Act (PPACA). Specifically, states that are awarded grants to establish an exchange, but that subsequently terminate the exchange or transfer operations to another entity, must conduct an audit of how grant funds were used and return any acquired property and unobligated funds to the federal government, in accordance with specified requirements. Such states must also refer matters involving fraud, waste, and abuse of PPACA funds to the Department of Justice.

Resolution· HRESH.Res. 16 (116th)referred

Recognizing the importance of access to comprehensive, high-quality, life-affirming medical care for women of all ages.

United States · United States Congress · 3 January 2019

This resolution expresses support for women nationwide to have access to comprehensive, convenient, compassionate, life-affirming, and high-quality health care. The resolution also recognizes the high standards established by the Pro Women's Healthcare Centers consortium as standards worth implementing nationwide.

Bill· HRH.R. 80 (116th)referred

Phoenix VA Congressional Oversight Act

United States · United States Congress · 3 January 2019

Phoenix VA Congressional Oversight Act This bill directs the Department of Veterans Affairs (VA) to carry out a pilot program in Arizona, including at the VA's Phoenix health care system, to improve the ability of Members of Congress to assist constituents with VA medical benefits issues. The VA must establish a dedicated congressional relations team to assist congressional members and committees with casework issues at each VA health care system location in Arizona.

Bill· HRH.R. 23 (116th)referred

Care Veterans Deserve Act of 2019

United States · United States Congress · 3 January 2019

Care Veterans Deserve Act of 2019 This bill expands and makes permanent the Veterans Choice Program. The program allows eligible veterans to receive health care in their communities rather than at a Department of Veterans Affairs (VA) facility when certain hardships exist (e.g., when a veteran resides more than 40 miles from a VA facility). The bill expands program eligibility to include veterans with a service-connected disability rated at 50% or more. Additionally, the bill requires the VA to contract with a national chain of walk-in clinics to provide hospital care and medical services in such clinics to veterans who are in the annual patient enrollment system. The clinics may not require a preauthorization or a co-payment for treatment. Under the bill, an authorized health care professional may provide treatment via telemedicine at any location in any state, regardless of where such health care professional or the patient is located. The bill requires the VA to extend the operating hours for VA pharmacies and medical facilities. Finally, the VA may provide for a nongovernmental hospital organization best-practices peer review of each VA medical center.

PreviousPage 30 of 30